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Abstract
Objective—Functional deficits seen in several neurodegenerative disorders have been linked 
with dysfunction in fronto-striatal circuits and with associated shape alterations in striatal 
structures. The severity of visible white matter changes (WMC) on MRI has been found to 
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correlate with poorer performance on measures of gait and balance. This study aimed to determine 
whether striatal volume and shape changes were correlated with gait dysfunction.
Method—MRI scans and clinical gait/balance data (scores from the SPPB - Short Physical 
Performance Battery) were sourced from 66 subjects in the previously-published LADIS trial, 
which was performed in >65 y.o. non-disabled individuals with WMC at study entry. Data were 
obtained at study entry and at three-year follow-up. Caudate nuclei and putamina were manually 
traced using a previously published method, and volumes calculated. The relationships between 
volume and physical performance on the SPPB were investigated with shape analysis utilising the 
SPHARM toolkit.
Results—There was no correlation between the severity of WMC and striatal volumes. Caudate 
nuclei volume correlated with performance on the SPPB at baseline, but not at follow-up, with 
subsequent shape analysis showing regionalisation of left caudate changes in areas corresponding 
to inputs of the dorsolateral prefrontal, premotor and motor cortex. There was no correlation 
between putamen volumes and performance on the SPPB.
Conclusion—Disruption in frontostriatal circuits may play a role in mediating poorer physical 
performance in individuals with white matter changes. Striatal volume and shape changes may be 
suitable biomarkers for functional changes in this population.
Introduction
The Implications of White Matter Changes
White matter changes (WMC), defined as focal and confluent white matter hyperintensities 
on T2-weighted MRI brain scans, are particularly prominent in individuals over the age of 
65 [1, 2]. Previous studies have examined the correlation of white matter changes and 
cognitive ability in this older age group, with the largest being the Leukoaraiosis and 
Disability Study (LADIS). The LADIS study is a multi-centre European study which 
investigated the effect of WMC on a number of different clinical indicators over a three-year 
prospective follow-up [3, 4]. The LADIS study has demonstrated a number of associations 
between severity of WMC and adverse outcomes, which included increased transition to 
disability [5], greater incidence of depression [6, 7], as well as declining cognitive ability 
[8-12].
The LADIS study also demonstrated a significant association between the severity of 
WMC/WMH and the prevalence of gait and balance disorders – both in the frequency of 
falls and in poorer scores obtained on scales such as the Short Physical Performance Battery 
(SPPB) [13, 14]. This is consistent with recent literature identifying gait and balance 
disorders in the elderly as a marker of other serious morbidity and mortality, particularly 
through proxy measures such as walking speed, which has been linked to all-cause and 
cardiovascular mortality [15, 16] as well as subsequent development of dementia [17].
Fronto-Striatal Circuits and Striatal Shape Analysis
The link between the basal ganglia of the brain and motor co-ordination and planning is well 
documented [18-20]. While basal ganglia volumes have been the mainstay of MRI studies, 
studies of three dimensional shape alterations in the striatal areas of the basal ganglia, 
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particularly in the caudate nucleus, have been demonstrated in a number of studies 
examining different neurodegenerative disorders characterised by both motor abnormalities 
and dementia [21-25]. Our group has previously examined caudate nucleus volumetrics in 
patients with stroke and vascular dementia [26].
Afferents to the caudate arise from different areas of the cortex, making the caudate nucleus 
an important part of parallel fronto-striatal circuits [27]. This model, first described by 
Alexander et al, and confirmed through a number of different modalities [28-31], indicates 
that different areas of the cortex ‘map’ on to different areas of the caudate nucleus and 
putamen (Figure 1). Specifically, the cognitive and behavioural circuits arising from 
dorsolateral prefrontal cortex, anterior cingulate and orbitofrontal cortex primarily project to 
the caudate, while the frontal eye fields and motor cortex project to both caudate and 
putamen [27, 32]. Accordingly, functional changes in cognition, behaviour and movement 
may arise from structural change in caudate and putamen. Therefore, we hypothesized that 
motor function may be correlated with the structural integrity and hence morphology of the 
caudate and putamen and sought to examine this hypothesis through three dimensional 
shape analyses of these structures.
This study aimed to determine whether subjects entering the LADIS study had striatal shape 
reductions - ‘deflation” - in specific areas at baseline, corresponding to the site of afferent 
connections from cortical motor circuits. Our chief hypothesis was that we would detect 
shape deflation in striatal regions corresponding to areas of the motor cortex, and that this 
deflation would correlate with poorer performance on the Short Physical Performance 
Battery. Gait, measured via walking speed in the SPPB, has been associated with cognitive 
impairment and progression to dementia [33-35]. We further hypothesised that striatal 
morphology would be associated with walking speed. Finally, as LADIS is a longitudinal 
study, we sought to investigate these structure-function relationships with clinical data at 3 
year follow-up.
Methods
LADIS Study Data Collection and Details
The recruitment methods and other clinical data for LADIS have been documented 
elsewhere [3] in brief: 639 subjects were recruited from 11 centres in Europe: Florence, 
Helsinki, Graz, Lisboa, Amsterdam, Gothenburg, Huddinge, Paris, Mannheim, Copenhagen, 
and Newcastle-upon-Tyne. Inclusion criteria were an age range between 65 and 84 years, 
white matter changes as rated by the Fazekas Scale (as mild, moderate and severe) on T2 
and FLAIR MRI [36] – during the course of the study. WMC were also assessed via total 
WMC volume and through the Scheltens scale [37] but the different measurement methods 
did not result in any differences in correlations with gait or balance outcomes [38]. The 
other criterion for entry was a score on the International Activities of Daily Living (IADL)
[39] scale indicating no or mild disability. The exclusion criteria were the presence of severe 
medical or psychiatric illness, severe unrelated neurological diseases (specifically, this 
included any comorbid diagnoses of neurodegenerative disorders affecting the caudate 
nucleus such as Huntington’s Disease), non-vascular leukoencephalopathy, or inability to 
give informed consent.
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MRI scans were performed at baseline and at three years. A number of clinical indicators 
were measured at baseline and at yearly intervals, including measurements of disability, 
cognition, mood, gait, and medical events such as stroke.
The gait and balance measure utilised for the current study was the Short Physical 
Performance Battery (SPPB), which tests the ability of subjects to hold themselves in 
various standing positions (feet in side-by-side, semi-tandem or tandem), measures walking 
speed over an 8-foot course, and tests ability and speed at rising from a chair [40]. The 
SPPB is scored out of 15, with a higher score indicating a better performance.
MRI Acquisition
The MRI-protocol consisted of 3D sagittal or coronal T1-weighted magnetization prepared 
rapid acquisition gradient echo (MPRAGE) images (TE=4–7 ms; TR=10–25 ms; TI=100–
950 ms; flip angle=10–30°; voxel size=1×1×1–1.5 mm3; FOV=250mm), axial T2-weighted 
fast spin echo images (TE=100–120 ms, TR=4000–6000 ms, FOV=250 mm, slice thickness: 
5-7.5 mm, interslice gap 0.5 mm) and fluid attenuated inversion recovery (FLAIR) images 
(TE=100–140 ms, TR=6000–10,000 ms, TI=2000–2400 ms, FOV=250mm, slice thickness 
5–7.5mm, interslice gap 0.5mm). The scans were acquired at 1.5 T [preceding description 
modified from [41]].
Ethical Approval
The LADIS study received ethical approval from local ethics committees in each centre. We 
received permission from the principal investigators for our analysis of a subset of the MRI 
scans and associated clinical data, as well as local approval from the Australian National 
University Human Research Ethics Committee.
Caudate Nucleus and Putamen Tracing
A subset comprising approximately 10% of the sample (n=66) from the LADIS study were 
selected by the LADIS study group (by GS) from four LADIS centres – Copenhagen, 
Stockholm (Huddinge), Gothenburg and Helsinki. These centres were chosen in 
collaboration with one of the authors (GS) and selected due to image quality for tracing and 
availability. Scans were anonymised by LADIS group researchers before transfer to a 
MacBook Pro (Apple, Cupertino, CA, USA) computer provided by University of Melbourne 
based at the Department of Psychological and Addiction Medicine, Australian National 
University. Subjects with infarcts in the caudate or putamen were excluded.
DICOM (Digital Imaging and Communications in Medicine) files of T1-weighted images 
were converted to ANALYZE 7.5 format (Mayo BIR, Rochester, NY, USA) using 
MRIConvert (http://lcni.uoregon.edu/~jolinda/MRIConvert/) to prepare for analysis. Image 
intensity was standardised by using preset threshold values, based on a pilot analysis of the 
data, and voxel size was reconstructed as isotropic at 1x1x1mm. The intracranial volume 
(ICV) was determined in a semi-automated fashion using FSL software (FMRIB Group, 
Oxford) as a measure to control for brain size. First, brains were skull-stripped with the 
Brain Extraction Tool (BET) and were then linearly aligned to the MNI152 1mm T1-
weighted template. The inverse of the determinant of the affine transformation matrix was 
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multiplied by the ICV of the MNI152 template to produce a measure of ICV for use as a 
covariate [42].
Caudate nuclei and putamen were manually traced within ANALYZE 10.0b (Mayo BIR, 
Rochester, NY, USA) through a Region of Interest (ROI) approach on, by one investigator 
(MM) who was blind to clinical data, using a previously published protocol [43, 44] applied 
in a number of studies [26, 45-48]. Briefly, this involved tracing images in the axial plane, 
using the inferior border of the anterior commissure as the inferior boundary (see Figure 2). 
The resulting binary objects were checked in the sagittal plane, and volumes calculated. 
Reliability of the tracing was checked by an experienced tracer (JCLL) tracing basal ganglia 
on a representative sample of the 66 subjects; MM also retraced the representative sample to 
serve as test-retest reliability. Intraclass correlation coefficients were used to determine 
reliability of volumetric measurement – intra-rater reliability was 0.944, with inter-rater 
reliability 0.890. Decisions on whether to proceed to shape analysis were guided by 
volumetric results: if there was no significant volume change, shape analysis was not 
attempted. While it is possible to have shape change without volumetric change, and vice 
versa, our group’s experience is that shape analysis allows localisation of where significant 
volumetric differences occur. Furthermore, given that volumetric change is very rarely 
uniform, it follows that overall volume change is driven by a significant localised shape 
change.
Shape Analysis
Shape analysis was undertaken in a semi-automated fashion using the University of North 
Carolina shape analysis toolkit (http://www.nitrc.org/projects/spharm-pdm/); a detailed 
description of the methodology is available elsewhere [49, 50]. Segmented 3D binaries are 
initially processed to ensure interior holes are filled, followed by morphological closing and 
minimal smoothing. These are then subjected to spherical harmonic shape description 
(SPHARM), whereby boundary surfaces of each shape are mapped onto the surface of a 
sphere and the surface coordinates were represented through their spherical harmonic 
coefficients [51]. The correspondence between surfaces is established by parameter-based 
rotation, itself based on first-order expansion of the spherical harmonics. The surfaces are 
uniformly sampled into a set of 1002 surface points and aligned to a study-averaged 
template for each structure (left and right caudate and putamen) using rigid-body Procrustes 
alignment [52]. Scaling normalization was performed to remove the effect of head size/
intracranial volume, using a surface scaling factor: fi, where fi={Mean(ICV)/ICVi}1/3 [53].
Statistical Analyses
Volumetric data were analysed with paired t-tests to determine change in volume from 
baseline to 3-year follow-up. ANCOVA was performed to determine whether volume 
differences were present between severity subgroups as measured by baseline Fazekas score. 
Relationships between basal ganglia volumes and SPPB scores/walking speeds were 
assessed with hierarchical regression, with covariates (age, gender and intracranial volume) 
entered at the first step and the volumes entered at the second step.
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With regard to shape analysis, we compute non-parametric statistical tests that compare the 
local surface coordinates for group mean differences at the 1002 surface locations [49, 50, 
53]. A local group difference metric between groups of surface coordinates is derived from 
the Hotelling T2 two-sample metric [53]. As the shape analysis involves computing 1002 
hypothesis tests, one per surface location, a correction for multiple testing is necessary, as an 
uncorrected analysis would be overly optimistic. The shape analysis uses permutation tests 
over the Hotelling T2 metric for the computation of the raw uncorrected p-values and uses 
false discovery rate (FDR) [54] for multiple comparison correction. Correlational analyses 
were undertaken using Spearman’s rank-correlation co-efficient r, and maps of both r and 
FDR-corrected p-values are generated.
Results
Demographics, Longitudinal Change and Severity of White Matter Disease
Demographic details of the entire LADIS dataset have been reported [3]. The demographic 
details and severity of WMC in the LADIS subgroup included in this study were similar to 
that of the larger dataset. The rates of subsequent transition to disability or death were 
significantly lower in the study group compared to the rest of the LADIS group, while SPPB 
scores were not significantly different (Table 1). There was no significant relationship 
between basal ganglia volumes and the severity of WMC, whether the severity was assessed 
via the Fazekas scale, total summed WMC volume or Schelten scores (please see online 
supplementary materials). Longitudinal paired t-tests on baseline and follow-up basal 
ganglia volumes showed little change in volume over time, apart from some weakly 
significant increases in caudate volumes in some subsets (<5% of volume, see online 
supplementary material). I think you mean decreases in caudate volume Table 3 in the 
appendix reports shirnkage of the right caudate in the mild group and shrinkage of left 
caudate in the moderate group. This table is a bit confusing as a positive mean difference 
signifies shirnkage. It might bet better to reverese the sign ie make Mean difference = follow 
up volume minus baseline volume. Or have I got myself mixed up!!!
Volumetry
Initially, volumetric analysis was performed on the manually segmented 3-D objects of 
caudate and putamen. The results of these analyses guided the shape analysis explorations, 
based upon our group’s previous experience with shape analysis [24, 46-48]. Regression 
analysis on these volumes is shown in Table 2. A significant correlation was found between 
caudate nucleus volumes and both SPPB scores and the walking speed subcomponent of the 
SPPB at study baseline, but this was not reproduced at three-year follow-up. Intracranial 
volume was negatively correlated with SPPB at baseline, but not follow-up. There was no 
significant correlation between putamen volume and measures of gait or balance.
Shape Analysis
We applied the shape analysis method to the segmented caudate for the entire dataset. All 
results were scale-normalised for total intracranial volume. The results presented are based 
upon FDR corrected p-value maps, together with corresponding local displacement maps. 
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The details of the legend for the analyses are described below the images for ease of 
reference when reading the images (Figure 4).
Shape deflation was seen unilaterally in the left caudate nucleus, with no significant 
differences seen in the right caudate. Inward deformation of left caudate shape was found in 
regions corresponding to the inputs of the dorsolateral prefrontal, premotor and motor 
cortex, correlating with SPPB (p=0.0017) [32, 55, 56]. Localised shape changes were seen 
when analysing the walking speed subcomponent of the SPPB, but these did not persist 
when corrected for FDR.
Discussion
The current study, of older patients with white matter changes, has identified highly 
significant shape and volume deflation in areas of the left caudate nucleus that subserve 
motor portions of the fronto-striatal circuits. These results support our hypothesis, and 
demonstrate patterns similar to those seen in a number of neurodegenerative disorders that 
manifest structural change in the caudate nucleus such as Huntington’s Disease [57-59], 
Alzheimer’s Disease [60-63], Progressive Supranuclear Palsy [25, 64], Corticobasal 
Syndrome and Multiple System Atrophy [65-67]. Accordingly, morphometric (shape and 
volume) analysis of the caudate may be used as a biomarker which could aid in diagnostic 
clarity and as an additional marker to track the progression and treatment [68].
Within frontostriatal circuits, the caudate subserves a role in the supplementary motor 
circuit, connecting to premotor and motor cortex involved in the planning and execution of 
movements [32]. Impairment of gait and balance was correlated with altered morphology of 
the caudate. This finding suggests that motor dysfunction is associated with disruption of the 
supplementary motor frontostriatal circuit. This is borne out by the specific regional atrophy 
in the postero-lateral aspect of the left caudate. It has been proposed that a purpose of 
hemispheric lateralisation is to encode constrained repertoires of cognition, emotion and 
behaviour within the left hemisphere [69]. Thus, the specific atrophy of the left caudate may, 
in part, reflect the process of loss of the physical substrate of the entrained gait and balance 
behaviours under frontal control in frontostriatal circuits. A parsimonious explanation for 
lateralization may be that the corresponding morphologic change was not detected in the 
right caudate due to sample size.
The lack of correlation between white matter lesion load and striatal volumes, and between 
caudate morphology and SPPB at follow-up may be partially explained by a survivor effect, 
i.e. the selection of a group for which MRI were available in 3-year follow-up necessarily 
resulted in a sample biased to lesser severity of disability in general (as seen in Table 1). 
Thus a correlation evident at baseline may have much less predictive value and hence 
correlation at follow-up. This survivor effect may also, in part, be responsible for the lack of 
atrophy demonstrated in basal ganglia volumes over this period (see online supplementary 
material) – indeed, there was a statistically significant (although small, <5%) increase in 
caudate volumes of some subsets, which may reflect some compensation as the patient ages 
but is more likely to be a statistical artefact. The small but highly significant negative 
correlation between intracranial volume and SPPB at baseline implies higher ICV is 
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correlated with lower SPPB, signifying poorer motor function. That this is not replicated in 
the 3-year follow-up may also represent a survivor effect, but is admittedly difficult to 
explain.
The possible mechanisms of caudate morphology alterations in WMC are admittedly 
speculative. These mechanisms comprise: possible deafferentation of striatal inputs through 
direct anatomical disruption by white matter hyperintensities [68], direct vascular damage to 
the caudate and generalised cerebral atrophy as a result of WMC. We consider the former 
most likely, and at least in our study, the latter two factors were controlled for by exclusion 
and as a covariate/scaling respectively.
Limitations of this study include the small sample size. However, as manual tracing is a 
time-intensive process, the size of this study compares favourably to other shape analysis 
studies utilising similar methodology [46-48]. Replication of these results, particularly the 
preponderance of left-sided deflation, will be useful in order to confirm the degree and 
laterality of shape deflation in individuals with diffuse white-matter hyperintensities. 
Analysing the rest of the LADIS dataset would be a useful next step, but the large number of 
scans (600+) involved may require a more automated and less manually intensive 
segmentation method.
Conclusion
We have demonstrated that the caudate nucleus may be a possible physical substrate and 
hence, a potential biomarker, for gait and balance in persons with WMC. Recent related 
research has highlighted that impaired gait, measured as walking speed, is associated with 
both progression to dementia and increased mortality [33-35]. Thus having identified a 
possible physical substrate and component of frontostriatal circuits implicated in cortical 
control of gait and balance is a significant advance. In addition, we have demonstrated a 
correlation between caudate morphology, responsible for mediation of motor function, and a 
measure of gait, balance and walking speed. We propose that these methods of shape 
analysis of the striatum should be applied, with the advance of automated segmentation, to 
the entire LADIS dataset, and similar datasets to determine if our findings may be 
replicated, and extended by correlation with automated quantification of white matter 
hyperintensities. Thus we may derive a reliable neuroimaging biomarker of cognitive and 
gait dysfunction in cerebrovascular disease, suitable for monitoring disease progression and 
potentially predictive of dementia and adverse outcomes.
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Figure 1. 
Striatal afferent connections, showing the location on the caudate and putamen that each 
cortical region preferentially connects, based on the circuit diagrams from Alexander et al 
1986.
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Figure 2. 
Diagram demonstrating the functional organisation of A. frontal cortex and B. striatal 
afferent projections. (A) Schematic illustration of functional connections linking frontal 
cortical brain regions. (B) Organisation of cortical and subcortical inputs to the striatum. In 
both (A) and (B), the colours denote functional distinctions. Blue: motor cortex, execution 
of motor actions; green: premotor cortex, planning of movements; yellow: dorsal and lateral 
prefrontal cortex, cognitive and executive functions; orange: orbital prefrontal cortex, goal-
directed behaviours and motivation; re: medial prefrontal cortex, goal-directed behaviours 
and emotional processing. Reproduced with permission from Haber, 2003.
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Figure 3. 
Representative slices from manual tracing of the caudate nuclei, above, and the putamina, 
below.
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Figure 4. 
Shape analysis correlating specific areas of the caudate nucleus with performance on the 
Short Physical Performance Battery (SPPB) at study entry. Clockwise from L top (three 
images per structure) : 1a,b,c: Left caudate ventral aspect, 2a,b,c: R caudate ventral aspect, 
3a,b,c: R dorsal aspect, 4a,b,c: L caudate dorsal aspect. The anterior aspect of the caudate is 
oriented towards the bottom of the image. Raw P value: unadjusted P value; FDR P value: 
false discovery rate P value (adjustment for family-wise error); Spearmans r: Spearman’s 
rank correlation coefficient for SPPB with caudate surface. Scale for images is displayed in 
the colour bar at the side of the respective images.
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Table 1
Demographic Details
Variable Study group
n=66
Rest of LADIS
study (n=573)
Significance of
Difference on t-
test/chi-square
Age in years – mean (SD) 73.2 (4.97) 74.2 (5.05) 0.115 (NS)
Gender – % male 51.5 44.3 0.262 (NS)
Mean Caudate Volumes (mm3)* 2695.4 N/A N/A
Mean Putamen Volumes (mm3)* 2195.5 N/A N/A
Mean Intracranial Volume (cm3) 1567.9 N/A N/A
Leukoaraiosis – % mild 39.7 45 0.705 (NS)
Leukoaraiosis – % mod 33.8 30.5 0.705 (NS)
Leukoaraiosis – % severe 26.5 24.5 0.705 (NS)
% who transitioned to disability or
death at 3 years
25.8 39.6 0.035*
Average SPPB scores at Baseline 9.80 9.74 0.846 (NS)
Average SPPB scores at 3-Year
Follow-Up
9.69 9.11 0.119 (NS)
Average Walking Speed at Baseline
(m/sec)
1.15 1.19 0.127 (NS)
Average Walking Speed at 3-Year
Follow-up (m/sec)
1.17 1.11 0.508 (NS)
*
Right plus left volumes
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Table 2
Caudate Nucleus Volumetry Regression Analyses (Model 2)
Variable Time Point Variable Standardized
Beta
Sig. Correlations
Partial Part
SPPB
Score
Baseline/Study
Entry
Age −.243 .040* −.278 −.232
Gender −.159 .261 −.154 −.125
Intracranial
Volume
−.370 .009* −.350 −.300
Bilateral Caudate
Volume
.350 .003* .390 .340
3-Year Follow-
up
Age −.314 .027* −.307 −.302
Gender −.059 .721 −.051 −.048
Intracranial
Volume
.095 .555 .084 .079
Bilateral Caudate
Volume
.191 .167 .194 .186
Walking
Speed
Baseline/Study
Entry
Age −.427 .001* −.449 −.412
Gender −.185 .194 −.176 −.147
Intracranial
Volume
−.274 .047* −.266 −.227
Bilateral Caudate
Volume
.340 .005* .373 .330
3-Year Follow-
up
Age −.383 .005* −.385 −.368
Gender −.130 .412 −.117 −.104
Intracranial
Volume
−.266 .086 −.243 −.221
Bilateral Caudate
Volume
.220 .096 .236 .214
Model 1 = Age, Gender, Intracranial volume Model 2 = Age, Gender, Intracranial volume, Bilateral caudate volume
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Table 3
Putamen Volumetry Regression Analyses (Model 2)
Variable Time Point Variable Standardized
Beta
Sig. Correlations
Partial Part
SPPB
Score
Baseline/Study
Entry
Age −.259 .046* −.268 −.248
Gender −.288 .059 −.254 −.233
Intracranial
Volume
−.441 .005 −.371 −.355
Bilateral Putamen
Volume
−.084 .519 −.088 −.079
3-Year Follow-
up
Age −.290 .045* −.257 −.279
Gender −.097 .569 −.068 −.081
Intracranial
Volume
.077 .642 .099 .066
Bilateral Putamen
Volume
.001 .993 .077 .001
Walking
Speed
Baseline/Study
Entry
Age −.400 .002* −.371 −.397
Gender −.271 .074 .007 −.241
Intracranial
Volume
−.328 .032 −.216 −.286
Bilateral Putamen
Volume
.022 .863 .008 .024
3-Year Follow-
up
Age −.355 .012* −.344 −.350
Gender −.173 .295 .073 −.149
Intracranial
Volume
−.288 .077 −.229 −.250
Bilateral Putamen
Volume
.008 .954 −.011 .008
Model 1 = Age, Gender, Intracranial volume Model 2 = Age, Gender, Intracranial volume, Bilateral putamen volume
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